Publication:
SEOM clinical guideline on hereditary colorectal cancer (2019).

Simple item page
dc.contributor.authorGuillen-Ponce, C
dc.contributor.authorLastra, E
dc.contributor.authorLorenzo-Lorenzo, I
dc.contributor.authorMartin Gomez, T
dc.contributor.authorMorales Chamorro, R
dc.contributor.authorSanchez-Heras, A B
dc.contributor.authorSerrano, R
dc.contributor.authorSoriano Rodriguez, M C
dc.contributor.authorSoto, J L
dc.contributor.authorRobles, L
dc.date.accessioned2023-02-08T14:40:00Z
dc.date.available2023-02-08T14:40:00Z
dc.date.issued2019-12-16
dc.description.abstractIn the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.
dc.description.versionSi
dc.identifier.citationGuillén-Ponce C, Lastra E, Lorenzo-Lorenzo I, Martín Gómez T, Morales Chamorro R, Sánchez-Heras AB, et al. SEOM clinical guideline on hereditary colorectal cancer (2019). Clin Transl Oncol. 2020 Feb;22(2):201-212
dc.identifier.doi10.1007/s12094-019-02272-y
dc.identifier.essn1699-3055
dc.identifier.pmid31981079
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-019-02272-y.pdf
dc.identifier.urihttp://hdl.handle.net/10668/15004
dc.issue.number2
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number201-212
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s12094-019-02272-y
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAdenomatous polyposis
dc.subjectColon cancer
dc.subjectHereditary colorectal cancer
dc.subjectLynch syndrome
dc.subject.decsMutación
dc.subject.decsNeoplasias colorrectales
dc.subject.decsOncología médica
dc.subject.decsPredisposición genética a la enfermedad
dc.subject.decsProteínas de neoplasias
dc.subject.decsSociedades médicas
dc.subject.meshClinical trials as topic
dc.subject.meshColorectal neoplasms
dc.subject.meshGenetic predisposition to disease
dc.subject.meshHumans
dc.subject.meshMedical oncology
dc.subject.meshMutation
dc.subject.meshNeoplasm proteins
dc.subject.meshPractice guidelines as topic
dc.subject.meshSocieties, medical
dc.titleSEOM clinical guideline on hereditary colorectal cancer (2019).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number22
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Guillen-Ponce_SEOMClinical.pdf
Size:
660.92 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía